Paola Patrignani and Carlo Patrono, “Cyclooxygenase Inhibitors: From Pharmacology to Clinical Read-outs,” Biochimica Et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1851, no. 4 (September 28, 2014): 422–32, https://doi.org/10.1016/j.bbalip.2014.09.016.
M Yusoff Dawood, “Primary Dysmenorrhea,” Obstetrics and Gynecology 108, no. 2 (August 1, 2006): 428–41, https://doi.org/10.1097/01.aog.0000230214.26638.0c.
K. D. Rainsford, “Ibuprofen: Pharmacology, Efficacy and Safety,” Inflammopharmacology 17, no. 6 (November 20, 2009): 275–342, https://doi.org/10.1007/s10787-009-0016-x.
U.S. Food and Drug Administration (FDA). “Mefenamic Acid Label Information.” Diakses April 2026.
National Health Service. “Ibuprofen: Uses and Safety.” Diakses April 2026.
Christopher J Derry et al., “Single Dose Oral Ibuprofen for Acute Postoperative Pain in Adults,” Cochrane Database of Systematic Reviews 2019, no. 5 (July 3, 2009): CD001548, https://doi.org/10.1002/14651858.cd001548.pub2.
Angel Lanas and Francis K L Chan, “Peptic Ulcer Disease,” The Lancet 390, no. 10094 (February 25, 2017): 613–24, https://doi.org/10.1016/s0140-6736(16)32404-7.
Rossi, S. "Australian Medicines Handbook." Adelaide: AMH Pty Ltd, 2021. Diakses April 2026.
Michèle Bally et al., “Risk of Acute Myocardial Infarction With NSAIDs in Real World Use: Bayesian Meta-analysis of Individual Patient Data,” BMJ 357 (May 9, 2017): j1909, https://doi.org/10.1136/bmj.j1909.